2025 Regular Session • Texas Legislature
HB3086
Legislative Summary
Relating to requirements for pharmaceutical drug manufacturers to report prescription drug costs.
Demographic Impact
Overall analysis of equity impact
75% Positive
Medium ConfidenceView detailed demographic breakdown ↓Unlock Full Demographic Insights
Go beyond the overall score.
Gain a deeper understanding of this bill's potential impact across diverse communities, including detailed breakdowns by category and subgroup. Access to this granular analysis helps ensure equitable outcomes.
Enable full analysis features for your organization.
Contact Sales to Learn MoreOr email us directly at sales@legiequity.us.
Bill History
2/20/2025
Filed
House of Representatives
3/20/2025
Read first time
House of Representatives
3/20/2025
Referred to Public Health
House of Representatives
Status Information
Current Status
Introduced(2/20/2025)
Chamber
House of Representatives
Committee
Public Health(House of Representatives)
Sponsors
Republican: 1
Primary Sponsor
Tom Oliverson
Republican